Alerts will be sent to your verified email
Verify EmailMETROPOLIS
Metropolis Health.
|
Dr. Lal Pathlabs
|
Thyrocare Tech.
|
|
---|---|---|---|
Operational Metrics
|
|||
Diagnostics
|
|||
Number of Diagnostic Centres
|
209.0 . | 277.0 . | n/a |
Realization/Patient - Diagnostic Centres
|
1053.0 Rs/Patient | 754.0 Rs/Patient | n/a |
Number of Daily Patients - Diagnostic Centres
|
34.0 Ths | 80.0 Ths | 45.75 Ths |
Realization/Test - Diagnostic Centres
|
501.0 Rs/Test | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
20.1 % | 20.39 % | 21.92 % |
5yr average Equity Multiplier
|
1.71 | 1.37 | 1.35 |
5yr Average Asset Turnover Ratio
|
0.78 | 0.93 | 0.83 |
5yr Avg Net Profit Margin
|
14.74 % | 15.97 % | 19.57 % |
Price to Book
|
7.22 | 10.68 | 9.11 |
P/E
|
56.16 | 47.62 | 54.42 |
5yr Avg Cash Conversion Cycle
|
-95.51 Days | -120.56 Days | -5.15 Days |
Inventory Days
|
12.81 Days | 9.03 Days | 17.88 Days |
Days Receivable
|
37.5 Days | 12.15 Days | 41.03 Days |
Days Payable
|
137.0 Days | 121.86 Days | 51.63 Days |
5yr Average Interest Coverage Ratio
|
12.67 | 18.41 | 72.56 |
5yr Avg ROCE
|
22.23 % | 26.98 % | 28.32 % |
5yr Avg Operating Profit Margin
|
26.81 % | 26.39 % | 32.43 % |
5 yr average Debt to Equity
|
0.07 | 0.08 | 0.01 |
5yr CAGR Net Profit
|
0.08 % | 9.63 % | -4.3 % |
5yr Average Return on Assets
|
11.78 % | 14.9 % | 16.06 % |
Shareholdings
|
|||
Promoter Holding
|
48.9 % | 53.91 % | 71.06 % |
Share Pledged by Promoters
|
1.18 % | 0.0 | 100.0 % |
Change in Promoter Holding (3 Yrs)
|
-0.89 % | -1.32 % | -0.12 % |
Change in Mutual Fund Holding (3 Yrs)
|
12.28 % | 9.52 % | 8.41 % |
Metropolis Health.
|
Dr. Lal Pathlabs
|
Thyrocare Tech.
|
|
---|---|---|---|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Distribution Channel
|
Distribution Channel
|
Distribution Channel
|
Distribution Channel
|
Customer Segment
|
Customer Segment
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|
Test Mix
|
Test Mix
|
-
|
-
|